Registration

Indications

BKEMV^™ (eculizumab-aeeb) is indicated for the treatment of:

patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.
patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy.
generalized myasthenia gravis (g... Read More

CREATE A NEW ACCOUNT

Account Information

Please complete the information below to create an account. If you already have an account and would like to log in, click here.
* Indicates a required field.

*I am a..

*Specialty

*First name

*Last name

*Institution

*NPI

*Email

*Phone Number

*Address 1

Address 2

Address 3

*City

*State

*Zip

Create Login

*Username

*Password

*Confirm Password